Home
Conditions
Adenocarcinoma

Clinical trial condition

Adenocarcinoma

Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.

126 public trials 17 recruiting studies

Refine in advanced search Browse all conditions

Adenocarcinoma trial results

Enrolling by invitation

Use of Tracking Devices to Locate Abnormalities During Invasive Procedures

NCT00102544

Conditions: Abnormalities, Multiple, Adenocarcinoma, Angiomatosis, +33 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Active, not recruiting

Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells Delivered Intraperitoneally for the Management of Platinum Resistant Ovarian Cancer, Mesonephric-like Adenocarcinoma, and Pancreatic Cancer

NCT05922930

Conditions: Adenocarcinoma, Adnexal Diseases, Carcinoma, +22 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, not recruiting

Chemo4METPANC Combination Chemokine Inhibitor, Immunotherapy, and Chemotherapy in Pancreatic Adenocarcinoma

NCT04543071

Conditions: Adenocarcinoma, Adenocarcinoma of the Pancreas, Carcinoma, +11 more
Locations: Columbia University Irving Medical Center New York, United States

Brown University Providence, Rhode Island, United States

Medical College of Wisconsin, Wisconsin Diagnostic Labratories Milwaukee, Wisconsin, United States

Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

View Trial Details

Active, not recruiting

Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma

NCT04069273

Conditions: Adenocarcinoma, Carcinoma, Digestive System Diseases, +11 more
Locations: Mayo Clinic- Minnesota Rochester, Minnesota, United States

Froedtert and The Medical College of Wisconsin Milwaukee, Wisconsin, United States

View Trial Details

Active, not recruiting

A Study of JNJ-69086420, an Actinium-225-Labeled Antibody Targeting Human Kallikrein-2 (hK2) for Advanced Prostate Cancer

NCT04644770

Conditions: Adenocarcinoma, Carcinoma, Genital Diseases, +11 more
Locations: Mayo Clinic Arizona Phoenix, Arizona, United States

City of Hope Duarte, California, United States

Mayo Clinic in Florida Jacksonville, Florida, United States

University of Chicago Chicago, Illinois, United States

View Trial Details

Active, not recruiting

A Pilot Study to Assess Changes in Tumor Biology Following Second-line Treatment With Pembrolizumab Plus Lenvatinib in Patients With Advanced Pancreatic Ductal Adenocarcinoma

NCT05273554

Conditions: Adenocarcinoma, Carcinoma, Neoplasms, +3 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, not recruiting

Assessment of Response Before, During and After Neoadjuvant Chemoradiotherapy in Rectal Cancer Patients

NCT01171300

Conditions: Adenocarcinoma, Carcinoma, Colorectal Neoplasms, +12 more
Locations: University Hospitals Gasthuisberg Leuven, Vlaams-Brabant, Belgium

View Trial Details

Active, not recruiting

Perioperative mFOLFOX Plus Pembrolizumab in Gastroesophageal Junction (GEJ) and Stomach Adenocarcinoma

NCT03488667

Conditions: Adenocarcinoma, Carcinoma, Digestive System Diseases, +11 more
Locations: The University of Kansas Cancer Center Westwood, Kansas, United States

View Trial Details

Completed

A Phase 2 Trial of High-dose Ascorbate for Pancreatic Cancer (PACMAN 2.1)

NCT02905578

Conditions: Adenocarcinoma, Cancer of Pancreas, Cancer of the Pancreas, +14 more
Locations: Holden Comprehensive Cancer Center Iowa City, Iowa, United States

View Trial Details

Completed

Dose Escalation Study Using Ultra-Hypofractionated, Image-Guided, Intensity-Modulated Radiotherapy in Prostate Cancer

NCT00911118

Conditions: Adenocarcinoma, Carcinoma, Genital Diseases, +12 more
Locations: Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States

Memorial Sloan Kettering West Harrison Harrison, New York, United States

Memorial Sloan Kettering Cancer Center New York, United States

Memorial Sloan Kettering at Mercy Medical Center Rockville Centre, New York, United States

View Trial Details

Adenocarcinoma

Adenocarcinoma trial results

Related conditions